CodonRX was founded during the midst of the COVID-19 pandemic, which served as a stimulus, forcing us to consider ways to improve the affordability and accessibility of high-quality, pharmaceutical products, globally.
Our groundbreaking strain, patented as NCK2025, is the result of over a decade of rigorous scientific research focused on understanding the biology and genetics of the Lactobacillus acidophilus probiotic.
From this, CodonRX was developed and combines the most advanced technologies in microbial biology to accelerate or promote general gut wellness by shielding the gut lining and eliminating inflammatory fatty acids.
At CodonRX we believe products based on cutting-edge science should be accessible and affordable. We look forward to continuing this journey together and bringing this high impact probiotic to consumers.
Company Details
- Address
- San Jose, Us
- Industry
- Retail Health And Personal Care Products
- NAICS
-
Health and Personal Care StoresPharmacies and Drug StoresCosmetics, Beauty Supplies, and Perfume StoresOptical Goods StoresOther Health and Personal Care StoresFood (Health) Supplement StoresAll Other Health and Personal Care Stores
- Website
- http://www.codonrx.com
- HQ
- San Jose
Codonrx Questions
Codonrx's website is http://www.codonrx.com
Codonrx's LinkedIn profile is https://www.linkedin.com/company/codonrx
Codonrx's industry is
Retail Health and Personal Care Products
Codonrx's top competitors are
Revelstoke Capital Partners,
Fundamental Research Labs,
Da Vinci Labs,
Noovo,
The Optimal Female,
Swaive,
Breyer Capital,
Chai Discovery,
Mirxes,
Future4care.
Codonrx's categories are Retail Health and Personal Care Products
